The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Biogen Australia Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
29 result(s) found, displaying 11 to 20
-
Cancellation by sponsorRequested by Biogen Australia Pty Ltd
-
Cancellation by sponsorRequested by Biogen Australia Pty Ltd
-
Prescription medicine decision summaryTGA Decision: Vumerity (diroximel fumarate) is approved to treat relapsing multiple sclerosis.
-
Prescription medicine registrationActive ingredients: diroximel fumarate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SPINRAZA nusinersen (as heptadecasodium) 12 mg/ 5 mL solution for injection vial.
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Nusinersen (as heptadecasodium)
-
Cancellation by sponsorRequested by Biogen Australia Pty Ltd
-
Cancellation by sponsorRequested by Biogen Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PLEGRIDY peginterferon beta-1a (rch) 125 microgram/0.5 mL solution for injection pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PLEGRIDY peginterferon beta-1a (rch) 63 microgram/0.5 mL and 94 microgram/0.5 mL solution for injection pre-filled syringe TITRATION PACK.